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BACKGROUND: Periodontal disease is associated with 
cardiovascular diseases because of its role in host immune-
inflammatory response. Serum lipids are the commonest risk factors 
between periodontal disease and cardiovascular diseases.  
MATERIALS AND METHOD: A double blinded randomised clinical 
trial was carried out among 45 subjects with generalised severe 
periodontitis. They were divided into 3-groups of 15 subjects each. 
Group A: 0.25% lemongrass oil mouthwash, Group B: 0.12% 
chlorhexidine mouthwash and Group C: Oral prophylaxis only Group. 
Oral examinations like assessment of Probing Pocket Depth and 
Clinical Attachment Loss and Bio-chemical tests like assessment of C-
Reactive Protein, Total Cholesterol, High Density Lipid, Low Density 
Lipid and triglycerides were conducted at baseline followed by oral 
prophylaxis at the same visit. Reassessment of the above mentioned 
parameters were done after 3 months of intervention. Data so collected 
were subjected for statistical analysis using SPSS ver. 20.0.  
RESULTS: A statistically significant reduction in C-Reactive Protein, 
Probing Pocket Depth, Clinical Attachment Loss, Total Cholesterol 
and Low Density Lipid level in 0.25% lemongrass oil mouthwash 
group was found. On comparing a statistically significant difference 
was observed for the post intervention scores of Probing Pocket Depth 
and Clinical Attachment Loss only; for Group A v/s C and Group B 
v/s C. 
CONCLUSION: 0.25% Lemongrass oil mouthwash was found to be a 
good herbal alternative; both in the treatment of chronic periodontitis 
and reduction in the level of serum markers of Cardio Vascular 
Diseasess. 
KEYWORDS: Non-surgical therapy, C- reactive protein, Lipid Profile 
 
INTRODUCTION  
Periodontitis is a chronic inflammatory disease of infectious nature 
(1). It may affect systemic inflammatory burden significantly, which 
would result in endothelial dysfunction, atherosclerotic plaque 
instability, dyslipidemia and insulin resistance depending on the 
severity of periodontitis (2). Several studies indicated that subjects 
with periodontal disease may have a higher risk for cardiovascular  
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diseases (CVDs) when compared to subjects with 
a healthy periodontium (3). 
Periodontitis has been strongly associated 
with elevation of systemic inflammatory markers, 
such as C-reactive protein (CRP) (4), which is 
considered as an independent predictor of 
cardiovascular disease (CVDs) (5), including 
coronary heart disease (CHD) (6). C-reactive 
protein levels are elevated in severe chronic 
periodontitis subjects, and most intervention 
studies reported that periodontal treatment 
decreased the levels of systemic inflammatory 
cytokines in systemic healthy subjects. 
Hyperlipidaemia is a state with an abnormal 
lipid profile, which is characterized by elevated 
blood concentrations of triglycerides, elevated 
levels of total cholesterol and Low Density 
Lipoprotein (LDL) and decreased levels of High 
Density Lipoprotein (HDL) cholesterol (7). 
Periodontitis related atherogenic alterations are 
also associated with lipoprotein metabolism 
(8).There are common risk factors for periodontal 
disease. and CVDs. Serum lipids may be the most 
important among these factors (9). According to 
Katz J et al. (10) hyper-cholesterolaemia and 
CVDs are related to periodontal disease. 
Essential oils are ideal for use in oral care 
products because they are both antibacterial and 
nontoxic – a rare combination. Mouth washes 
containing essential oils are used for many years 
in the prevention and treatment of periodontal 
disease. Recent studies demonstrated that essential 
oil mouthwashes are as effective as chlorhexidine 
mouthwash in inhibiting the plaque regrowth (11) 
as they can penetrate the plaque biofilm, kill the 
pathogenic micro-organisms by disrupting their 
cell wall and inhibiting their enzymatic activity 
(12). Essential oil mouthwash prevents bacterial 
aggregation, slows their multiplication and 
extracts the bacterial endotoxins (13). The 
mechanisms by which essential oils can inhibit 
microorganisms may be due to their 
hydrophobicity, as a result of which they get 
partitioned into the lipid bilayer of the cell 
membrane, making it more permeable, leading to 
leakage of vital cell contents (14). Impairment of 
bacterial enzyme systems may also be a potential 
mechanism of action (15). 
Lemongrass oil is an essential oil, extracted from 
Lemon grass which belongs to the section of 
Andropogan called Cymbopogam of the family 
Germineae. The two of the major species are 
Cymbopogan citrates and C. flexuosus (16). It has 
a plethora of medicinal uses; antibacterial, 
antifungal, antioxidant, antiseptic, astringent, anti-
inflammatory, analgesic, antipyretic and 
carminative property (17), and its antibacterial and 
antifungal properties are comparable to that of 
penicillin in its effectiveness (18). 
An intra-oral source of infection like 
periodontitis can create an inflammatory immune 
response, thereby placing an apparently healthy 
individual at an increased risk for CVD. 
Periodontal disease can be treated and the risk of 
developing CVD can be reduced (19). Therefore, 
with a background of plaque control as a key 
factor for prevention of periodontal diseases, 
limited effectiveness of mechanical plaque control 
and linking the faith of people for herbal/natural 
products and potency of lemongrass oil the present 
study was conducted.  The aim was to investigate 
efficacy of non-surgical periodontal therapy with 
0.25% lemongrass oil mouthwash in reducing the 
risk of Cardiovascular Diseases [CVDs] in chronic 
periodontitis patients. 
 
MATERIALS AND METHOD 
 
This double blinded randomised controlled 
parallel designed clinical trial was planned with 
patients attending Kothiwal Dental College and 
Research Centre, Moradabad; following 
CONSORT guidelines for clinical trials (20). 
Based on a pilot study, to get a clinically 
significant difference between the groups, the 
necessary sample size was estimated using sample 
size and power calculations developed by William 
D. Dupont and licensed under a Creative 
Commons Attribution-Non Commercial-No 
Derivs 3.0 United States License.(21). A sample 
size of 12 subjects in each group was estimated 
considering 5% type I error and 20% type II error. 
Originally, 15 subjects were recruited in each 
group forecasting some amount of loss to follow-
up during the course of the study. 
Ethical clearance for the study was obtained 
from the Institutional Ethical Committee of 
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Kothiwal Dental College and Research Centre, 
Moradabad in India, and the examiner was 
calibrated so as to achieve a minimum kappa value 
of 0.80 for inter- and intra-examiner consistency. 
In order to ensure this, 5 patients were randomly 
selected and examined and re-examined for the 
Probing Pocket Depth (PPD) and Clinical 
Attachment Loss (CAL). The kappa value for 
intra-examiner reliability was found to be 0.85 and 
0.88 respectively. The examiner was trained to 
match the ability of a gold standard examiner, to 
check for this, inter-examiner reliability testing 
was done for PPD and CAL of the same patients. 
The kappa statistics for this was found to be 0.82 
and 0.86 respectively. 
The inclusion criteria for the study was set as: 
patients aged 30- 50 years with generalized severe 
periodontitis (CAL: > 4 mm with minimum of 
30% affected site). Patients with any systemic 
diseases, is known to have  allergy for lemongrass 
derivatives, had received any antibiotic treatment 
6 months prior to the study, unable to comply with 
the follow-up visit requirements, undergoing 
orthodontic treatment or any other treatment that 
may affect periodontal health, pregnant and 
nursing patients and patients who are suffering 
from oral disease that need emergency treatment 
like endo-perio lesion, periodontal abscess were 
excluded. 
A study sample of 45 patients who fulfilled 
the inclusion and exclusion criteria were recruited. 
Prior to recruitment, these subjects were made to 
sign informed consent after being described about 
the nature, potential risks and benefits of their 
participation in the study.  
All the 45 patients were randomly divided 
into 3 equal groups (Figure 1) by a periodontal 
expert who was not involved with the study to 
ensure blindingby balloting. They were also not 
aware of other parallel groups or mouthwashes 
used in this study. After that, the subjects were 
advised to follow thof their respective groups and 




Figure 1: Schematic representation of study design. 
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Group A: Lemongrass oil (0.25% ) mouthwash 
Group (n=15): Lemongrass oil mouthwash was 
prepared using the standard protocol in 
Department of Pharmacology, Kothiwal dental 
college and research centre. Patients were 
instructed to use 0.25% lemongrass oil mouthwash 
twice daily for 1 minute  for 3 months. Group B: 
Chlorhexidine (0.12%) mouthwash Group 
(n=15): Patients were supplied with commercially 
available 0.12% chlorhexidine mouthwash. They 
were instructed to use it twice daily for 1 minute 
for 3 months. Group C: Oral prophylaxis only 
Group (n=15): Patients were advised brushing 
with proper brushing technique being taught by a 
Periodontist. They were asked to brush twice 
daily: in the morning and last thing at night for 2-3 
minutes for 3 months. Group A and B were also 
instructed for the same brushing technique and 
regime along with use of mouthwashes for the 
entire study period. 
Modified bass technique was demonstrated to 
the subjects, and they were also supplied with new 
toothbrushes of same make and brand to maintain 
the uniformity at the commencement of the 
experimental period. The participants were 
instructed by the examiner on the use of 
mouthwash and brushing, and regular performance 
was reinforced every 3 days through telephone 
calls to ensure compliance.  
The oral examinations were conducted in the 
Department Of Public Health Dentistry, and bio-
chemical tests were done in the Department of 
General Pathology, Kothiwal Dental College and 
Research Centre, Moradabad. Oral examination 
included assessing PPD, and CAL and Bio-
chemical tests done were assessment of CRP, 
Total Cholesterol, HDL, LDL and triglycerides at 
baseline followed by oral prophylaxis at the same 
visit; subjects were again assessed after 3 months’ 
of intervention.  
Statistical analysis was carried out using 
SPSS ver. 20.0 (SPSS, Inc., Chicago, IL, USA). 
Levene’s test for homogeneity of variance 
(P<0.05) was performed, as we assumed equity of 
variance was more important than an assumption 
of normality. Hierarchical regression analysis was 
done to establish association between the 
independent variables and C- reactive protein in 
chronic periodontitis subjects. A comparison of 
the mean differences of the variables at baseline 
and post-intervention was analyzed by a paired t-
test and between the groups by one-way analysis 
of variance (ANOVA). Post hoc test (Tukey’s 
Test) was done to identify the significant pairs. 





Study subjects consisted of 45 individuals (Male: 
26, Female: 19) with chronic periodontitis. The 
mean age of the subjects was 43.52 ± 4.63. Table 
1 shows the mean distribution of CRP, TC, TG, 
HDL, LDL, PPD and CAL in Chronic 
Periodontitis subjects. Table 2 shows the 
hierarchical regression analysis done to find out 
the association between the independent variables 
and C- reactive protein in chronic periodontitis 
subjects (N=45). In the first model, only lipid 
profile parameters were taken into consideration,  
 
 
Table 1: Mean distribution of C - reactive protein, lipid profile and periodontal parameters in chronic 
periodontitis subjects 
 
Variables Mean ± SD 
C- reactive protein (mg/L) 1.75 ± 0.69 
Probing Pocket Depth (PPD) (mm) 5.12  ± 0.58 
Clinical Attachment Loss (CAL) (mm) 5.29  ± 0.56 
Total Cholesterol (mg/dl) 216.27 ± 38.70 
Triglycerides (mg/dl) 168.20 ± 31.53 
High Density Lipoprotein (HDL) (mg/dl) 41.04 ± 16.60 
Low Density Lipoprotein (LDL) (mg/dl) 140.04 ± 29.20 
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and this model was found to be statistically 
significant and total cholesterol was found out to 
be associated significantly with C- reactive 
protein. In the second model, along with lipid 
profile parameters, PPD and CAL were introduced 
into the first model. This model was also found to 
be statistically significant.  Total cholesterol along 
with PPD and CAL were found to be significantly 
associated with C- reactive protein.  
Table 3 shows the comparison of mean 
changes in C- reactive protein, lipid profile and 
periodontal parameters among all the three groups. 
It shows a statistically significant reduction in 
CRP, PPD, CAL, TC and LDL along with a 
significant increase in HDL level in the 0.25% 
lemongrass oil mouthwash group. On comparing 
between the groups, statistically significant 
difference was found for the post-intervention 
scores of PPD and CAL only, the significantly 
different groups being Group A v/s Group C and 
Group B v/s Group C for both PPD and CAL. 
 
Table 2: Hierarchical regression analysis showing the association between the independent 
variables and C- reactive protein in chronic periodontitis subjects (N=45) 
 
Model summary Coefficients# 
Model R R2 Adjusted 
R2 

















1 Constant 0.939 0.881 0.869 0.881 74.157 0.000* 74.157* -1.935 0.231 - 0.000* 
Total 
Cholesterol 
0.019 0.006 1.034 0.006* 
Triglycerides 0.001 0.002 0.029 0.773 
HDL -0.003 0.007 -0.084 0.616 
LDL 0.002 0.006 0.086 0.747 
2 Constant 0.965 .931 0.920 0.049 13.542 0.000* 84.954* -3.702 0.397 - 0.000* 
Total 
Cholesterol 
0.011 0.005 0.595 0.049* 
Triglycerides 0.002 0.002 0.113 0.175 
HDL -0.007 0.005 -0.170 0.203 
LDL 0.004 0.005 0.151 0.473 
PPD 0.308 0.132 0.273 0.025* 
CAL 0.524 0.172 0.422 0.004* 




This prospective double-blinded parallel designed 
clinical trial was conducted to investigate efficacy 
of non-surgical periodontal therapy with 0.25% 
lemongrass oil mouthwash in reducing the risk of 
Cardiovascular Diseases [CVDs] in the study 
participants. Comparisons were also made with 
gold standard 0.12% chlorhexidine mouthwash 
and oral prophylaxis only as control groups. To 
overcome the Hawthorne effect, these control 
groups were chosen (22). 
Hierarchical regression analysis in this study 
showed a statistically significant positive 
association between severity of periodontal 
disease (PPD, CAL) and CRP level. This was in 
agreement with prior evidence from 
epidemiological studies by Slade et al, (23). The 
possible mechanisms that connect focal infection 
in periodontitis with systemic cytokine levels 
might be that; the Tumor Necrosis Factor (TNF)-α 
stimulated the expression of Interleukin (IL)-6, 
which consequently augmented the CRP gene 
expression in the liver (24). Low levels of 
bacteremia may provide a stimulus for systemic 
inflammatory responses such as increased 
production of CRP due to activation of the cascade 
of inflammatory cytokine production by 
monocytes and other cells in the periodontal tissue 
and elsewhere (25). 
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Table 3: Comparison of mean changes in C- reactive protein, lipid profile and periodontal parameters among all the three groups 
VARIABLES 
 







Group A (N= 15) Group B (N= 15) Group C(N=15) 
C- reactive protein   (mg/L) Baseline 1.77 ± 0.69 1.72 ± 0.72 1.74 ± 0.72 0.017 0.983 - 
3 months 1.69 ± 0.65 1.66 ± 0.68 1.71 ± 0.68 0.018 0.982 - 
Δ (%) 0.08 ± 0.09 (4.51) 0.06 ± 0.07 (3.48) 0.03 ± 0.06 (1.72) - - - 
t- Value
$ 
(Significance) 3.66 (p= 0.003)* 3.15 (p= 0.007)* 1.74 (p= 0.104) - - - 
Probing Pocket Depth (PPD) 
(mm) 
Baseline 5.12 ± 0.55 5.13 ± 0.66 5.11 ± 0.66 0.002 0.998 - 
3 months 4.46 ± 0.55 4.48 ± 0.60 5.03 ± 0.03 4.402 0.018* A & C (p= 0.032) 
B & C (p= 0.040) 
Δ (%) 0.66 ± 0.19 (12.89) 0.65 ± 0.21 (12.67) 0.08 ± 0.07 (1.56) - - - 
t- Value
$ 
(Significance) 13.06 (p= 0.000)* 11.74 (p= 0.000)* 4.58 (p= 0.000)* - - - 
Clinical Attachment Loss 
(CAL) (mm) 
Baseline 5.31 ± 0.58 5.26 ± 0.59 5.32 ± 0.54 0.050 0.951 - 
3 months 4.75 ± 0.54 4.71 ± 0.53 5.23 ± 0.55 4.311 0.020* A & C (p= 0.049) 
B & C (p= 0.031) 
Δ (%) 0.56 ± 0.19 (10.54) 0.55 ± 0.19 (10.45) 0.09 ± 0.05 (1.69) - - - 
t- Value
$ 
(Significance) 11.69 (p= 0.000)* 11.37(p= 0.000)* 7.90 (p= 0.000)* - - - 
Total Cholesterol (mg/dl) Baseline 216.07 ± 44.61 216.80 ± 40.36 215.93 ± 32.97 0.002 0.998 - 
3 months 185.20 ± 45.64 198.60 ± 36.52 205.27 ± 32.88 1.045 0.361 - 
Δ (%) 30.87 ± 8.89 (14.28) 18.20 ± 9.86 (8.42) 10.67 ± 0.89 (4.94) - - - 
t- Value
$ 
(Significance) 13.45 (p= 0.000)* 7.15 (p= 0.000)* 45.92 (p= 0.000)* - - - 
Triglycerides (mg/dl) Baseline 169.13 ± 34.98 164.40 ± 30.71 171.07 ± 30.55 0.171 0.844 - 
3 months 151.13 ± 48.19 130.20 ± 31.14 164.67 ± 41.55 2.704 0.079 - 
Δ (%) 18.00 ± 40.61 (10.64) 34.20 ± 39.44 
(20.80) 
6.40 ± 41.16 (3.74) - - - 
t- Value
$ 
(Significance) 1.72 (p= 0.108) 3.36 (p= 0.005)* 0.602 (0.557) - - - 
High Density Lipoprotein 
(HDL) (mg/dl) 
Baseline 44.00 ± 19.61 36.67 ± 11.64 42.47 ± 17.73 0.807 0.453 - 
3 months 45.60 ± 19.65 37.47 ± 12.44 42.73 ± 16.90 0.927 0.404 - 
Δ (%) 1.6 ± 2.26 (3.63) 0.80 ± 3.17 (2.18) 0.27 ± 1.91 (0.62) - - - 
t- Value
$ 
(Significance) 2.74 (0.016)* 0.98 (0.344) 0.541 (0.597) - - - 
Low Density Lipoprotein 
(LDL) (mg/dl) 
Baseline 135.27 ± 33.11 145.93 ± 31.19 138.93 ± 23.00 0.505 0.607 - 
3 months 109.60 ± 33.85 134.93 ± 31.94 129.60 ± 25.98 2.861 0.068 - 
Δ (%) 25.67 ± 13.31(18.97) 11.00 ± 6.19 (7.53) 9.33 ± 9.22 (6.71) - - - 
t- Value
$ 
(Significance) 7.97 (p= 0.000)* 6.89 (p= 0.000)* 3.91 (p= 0.000)* - - - 






Tukey’s test; Δ Difference between baseline and 3 month’s score. 
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Post-treatment,  CRP levels reduced in all the 3 
groups, but the reduction was significant only in 
case of the groups who were given either of the 
two mouthwashes post oral prophylaxis. After 
periodontal therapy, some residual sites may have 
remained, and there may have been insufficient 
time for bio-chemical changes to be established 
after disease reduction. These results could also 
mean that non-surgical periodontal therapy alone 
was not able to bring down chronic inflammatory 
stimulus in these subjects. Reduction in CRP post-
periodontal therapy was consistent with previous 
studies by Tuter et al. (26) and Hussainet al (27). 
Highest reduction in CRP level was found in the 
0.25% lemongrass oil mouthwash group. This can 
be attributed to Citral, a component of lemongrass 
oil, which activates Peroxisome Proliferator-
Activated Receptor (PPAR) α and γ and 
suppresses expression of COX-2 (28). 
Local infection is considered to be a 
contributor to the systemic inflammation burden. 
In this study, post non-surgical periodontal 
treatment there has been significant reduction in 
PPD and CAL; so are the reduction in systemic 
markers of infection and lipid profile parameters. 
The statistically significant, highest reduction in 
PPD and CAL was seen in 0.25% lemongrass oil 
mouthwash group. From the results of this study, 
it can be implied that the lemongrass oil 
mouthwash can have an adjunctive effect on the 
treatment outcome used along with non-surgical 
periodontal therapy. This may be attributed to the 
fact that lemongrass essential oil could inhibit the 
growth of several kinds of microorganisms at a 
concentration less than or equal to 2%. The 
antioxidant activity of lemongrass oil the result of 
its contents such as citral (neral and geranial) and 
citronellal (29). In this study, both antimicrobial 
and antioxidant activities were achieved by using 
0.25% lemongrass essential oil in the mouthwash 
formulation. 
Citral can subside oxidative stress through 
Glutathione (GSH)’s antioxidant system induction 
because of its steroisomer, neral and geranial (30). 
It can also act via terminating the chain reaction of 
lipid metabolism by donating hydrogen to free 
radical (31). Flavonoid, a chemical component of 
lemongrass oil has many biological activities, viz., 
antioxidant, anti-inflammatory, antimicrobial, 
antimutagenic and anti tumour (32). Therefore, its 
activity can evade oxidation reaction along with 
reducing hydroxyl radical, peroxyl radical and 
superoxide (33). Citral is not only an active 
component of lemongrass oil but also helps in 
formation of Vitamin A and C; which are 
secondary antioxidants to scavenge free radicals 
and also prevents damage by stopping chain 
reaction (34). 
Lipopolysaccharides of dental plaque diffuse 
into the systemic circulation and they elicit a 
systemic lipopolysaccharide specific antibody 
response. This may lead to lipid metabolism 
disturbance and a hypercoagulable state through 
elevation of circulating cytokines (35). A possible 
explanation for the association between 
hyperlipidaemia and periodontal infection was 
postulated by Noack et al (36) by assessing 
neutrophil respiratory burst by whole blood 
chemiluminescence, and they found significant 
increases in both chemiluminescence and pocket 
depth on a group of patients with hyperlipidaemia. 
They suggested that the association of 
hyperlipidaemia with periodontitis could be due to 
the dysfunction of polymorphonuclear leukocytes.  
The result of this study shows that local 
periodontal treatment resulted in significant 
decrease in TC, LDL, and a significant rise in 
HDL level in the 0.25% lemongrass oil 
mouthwash group. In the 0.12 % chlorhexidine 
group, there was a significant reduction in serum 
TC, LDL, and TG and in oral prophylaxis group 
only TC and LDL levels were significantly 
reduced. The reduction of TC, LDL, TG and the 
rise in HDL after treatment suggests a potential 
effect of periodontitis-driven systemic 
inflammation on lipid metabolism.These findings 
are in accordance with a report by Pussinen et al 
(37) and Rao et al,  (38) who reported that 
periodontitis is associated with a reduction of the 
HDL levels and that periodontal therapy results in 
an increase in this anti-atherogenic lipid fraction. 
However, in another study conducted by D’Aiuto 
et al, (39) lipid marker changes were insignificant 
between standard periodontal treatment and 
control groups.  Though some reductions of TC 
and LDL were present only in the intensive 
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periodontal treatment group. There have been 
studies which reported that periodontal treatment 
is associated with the reduction of proatherogenic 
plasma lipid levels, i.e. TC and LDL as well as TG 
in patients with severe periodontitis (39, 40). 
Lemongrass oil decreases the level of TNF-α and 
IL-1, thus increasing production of lipoprotein 
lipase causing betterment in lipid metabolism (35). 
In conclusion, this clinical trial was limited 
by its small sample size and duration to cause 
change in systemic inflammatory markers. 
Therefore, large studies and clinical intervention 
trials are necessary to define whether these 
findings are true or are confounded by other 
important factors like nutrition, socioeconomic 
status or age. From a larger scale study, a better 
and precise comparison can be achieved. Within 
its limitations, this study indicated that non-
surgical periodontal therapy in chronic 
periodontitis patients could cause significant 
changes in the concentration of total cholesterol, 
triglyceride, HDL, LDL and C-Reactive Protein 
levels in blood serum. 
Lemongrass oil (0.25%) mouthwash was 
found to be a good herbal alternative to 0.12% 
chlorhexidine mouthwash. It can be an adjunct to 
non-surgical periodontal therapy both in the 
treatment of chronic periodontitis and reduction in 
the level of serum markers of CVDs. As it is one 
of the very few studies on the use of lemongrass 
oil as an active agent in mouthwash, so further 
studies on it with various other parameters are 
needed to know more of its beneficial and 
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